As pharmaceutical industry retreats, research and development for tuberculosis treatments, diagnostics and prevention relies more than ever on government support, and it’s dropping, Treatment Action Group report shows . . . LIVERPOOL, England – The chance to have the right people and the right information in the right place at the same time comes all too rarely […]
LIVERPOOL, England – While much of the focus at this conference focuses on the pursuit of new knowledge, to better treat, diagnose and prevent tuberculosis, a group of experts from leading institutions worldwide have put together everything they currently know about the disease in 23 pages. Among the points, lead author Madhukar Pai said today, as […]
HIV
To control the global health threat of HIV by 2030, according to UNAIDS, these goals must be reached by 2020: To diagnose 90 percent of all […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With more than 112,000 cases of measles reported by 170 countries so far this year, the world is seeing rising rates of a vaccine-preventable illness over […]